Background: Lithium is frequently used in the treatment of bipolar affectiv
e disorder, and is widely known to affect thyroid function, most commonly r
esulting in hypothyroidism and goiter, Less well-known is the association b
etween lithium therapy and hyperthyroidism and the potential for lithium to
moderate the effects of thyroxine at a cellular level. Lithium excretion r
elates principally to glomerular filtration rate and proximal tubule functi
on. Thyroxine, through its effects on tubular function, alters lithium clea
rance such that thyroid disease may cause retention of lithium and subseque
nt toxicity. Case Reports: We report 2 cases with Lithium toxicity, both of
whom were later found to be hyperthyroid, One patient developed thyroid st
orm following dialysis to remove lithium, The other received antithyroid me
dication early. Both suffered a protracted multifactorial delirium requirin
g intensive inpatient care, Conclusion: In addition to altering thyroid fun
ction, lithium therapy may mask the signs of hyperthyroidism by inducing ce
llular unresponsiveness. In some lithium-treated patients with biochemical
hyperthyroidism, early antithyroid treatment may be appropriate. Altered re
nal tubular function induced by hyperthyroidism may result in retention of
lithium and systemic toxicity. We propose induction of the proximal tubule
sodium hydrogen antiporter as the relevant mechanism.